crypto currency sign See results about

Soochow securities: It is expected that the Federal Reserve will cut interest rates by 25bps in December. According to the soochow securities Research Report, the CPI of the United States rebounded to +2.75% in November as scheduled, and the CPI that did not exceed expectations cleared the last obstacle for the Fed to cut interest rates in December. In the short term, the combination of low base and high viscosity means that CPI is expected to continue to rebound to +2.8% in December. In the medium term, Trump is expected to drive out illegal immigrants on the first day after taking office, which will aggravate the risk of stagflation in the labor market. However, the intensification of wage inflation stickiness may be concealed by the downward movement of non-agricultural centers in the same period, the expectation of increasing oil prices and the high base in the first half of 2025. The market's concern about "stagnation" may provide room for the Fed to cut interest rates smoothly in the first half of 2025. However, in the second half of 2025, the cumulative interest rate cuts will give support to the economy, the persistence of inflation stickiness and the landing of Trump's tax reduction policy will force the Fed to cut interest rates. It is expected that the Federal Reserve will cut interest rates by 25bps in December, 25bps in March and June next year, and stop cutting interest rates in the second half of the year. The end point of the policy interest rate in 2025 is [3.75,4.0]%.Morgan Stanley called concerns about South Korean financial stocks "excessive". Morgan Stanley said that recent political developments have hit South Korean financial stocks particularly hard because people are worried that reform efforts may be delayed and the risk of tightening supervision.CITIC Jiantou: The food and beverage industry is expected to usher in an inflection point. The CITIC Jiantou research report pointed out that 1) focusing on boosting consumption and expanding effective domestic demand, the food and beverage industry is expected to usher in an inflection point, and its performance and valuation are expected to continue to improve. The liquor sector is expected to rebound with the boost of the domestic economy and the activation of household consumption, and the business scene and mass consumption boom will return to the consumption upgrading channel, and the profitability of leading liquor companies is expected to accelerate the repair. At present, the overall valuation of the liquor sector is still at a low level, and the long-term investment value is prominent. 2) With the increase of policy stimulus, the pro-cyclical catering chain is expected to take the lead in benefiting from the expected improvement. Continue to be optimistic: 1) The leisure snacks and beverage industries maintain a high degree of prosperity, and new channels bring important incremental opportunities to companies in the industry; 2) In combination with the catering channels that continue to recover, it is suggested to pay attention to condiments, beer and catering chain labels with innovative products or reform expectations, and at the same time, the current molasses market price is further reduced from the previous month, which is of great help to yeast enterprises to improve their profit elasticity; 3) The inflection point of the raw milk cycle is approaching, the gift scene is expected to be repaired, and the dairy products continue to upgrade their structure, with high dividends and outstanding cost performance.

Onlikon: Compound α-keto acid tablets are planned to be selected for the tenth batch of national centralized drug procurement. Onlikon announced on December 13, and on December 12, the company participated in the bidding for the tenth batch of national centralized drug procurement organized by the National Drug Joint Procurement Office. After the bid opening and evaluation by the Joint Procurement Office, the company plans to select this centralized drug procurement. The indication of that medicine is to prevent and treat the damage caused by metabolic disorder in protein due to chronic renal insufficiency. The drug is a national medical insurance catalogue product, with an annual sales of 218,900 yuan in 2023, accounting for 0.01% of the company's annual operating income in 2023.Yingsi Intelligent announced that it had received a milestone payment of $10 million from Exelixis. On December 13th, Yingsi Intelligent, a biomedical technology company, announced that based on the progress made in the clinical stage of XL309(ISM3091) project, the company had recently received the first clinical milestone payment from Exelixis, with a total amount of $10 million.The restricted shares with a market value of 644 million yuan were lifted today. Xishan Technology, Betray and Wanda Bearing were among the top companies in terms of market value. On Friday (December 13th), the restricted shares of eight companies were lifted, with a total lifting amount of 20,925,400 shares. According to the latest closing price, the total lifting market value was 644 million yuan. Judging from the amount of lifting the ban, Betray, Xishan Technology and Nanwang Technology were among the top, with 9,834,300 shares, 3,706,800 shares and 3,247,500 shares respectively. Judging from the market value of lifting the ban, the number of shares lifted by 0 companies exceeded 100 million yuan. Xishan Technology, Betray and Wanda Bearing are among the top companies in terms of market value, with market values of 246 million yuan, 229 million yuan and 76.73 million yuan respectively. From the perspective of the proportion of shares released from the ban to the total share capital, Xishan Technology, Wanda Bearing and Nanwang Technology are among the top, with 7.47%, 3.08% and 1.66% respectively.

New Zealand wants to persuade the United States not to impose tariffs after Trump takes office. New Zealand Finance Minister Nicola Willis said that after US President-elect Donald Trump takes office, New Zealand should be exempted from imposing comprehensive tariffs, and asked officials to be sensible to the United States. "Our initial position was please don't do this," Willis said in an interview in Wellington. "We let diplomats show the best of New Zealand."The moderate increase in inflation in the United States consolidated the expectation of interest rate cuts in December. According to the data released by the US Department of Labor on December 11, local time, the US consumer price index (CPI) increased by 0.3% in November, an increase of 0.1 percentage point over October. Inflation continues to rise moderately, which is in line with the market's previous judgment and also supports the expectation that the Fed will continue to cut interest rates this month. However, considering the slowdown in inflation and the increase in uncertainties affecting the economy, many analysts believe that the Fed may slow down the pace of interest rate cuts in the future. (Economic Information Daily)Haitong Securities: The moderate price reduction of traditional Chinese medicine varieties continues. The domestic pharmaceutical industry is expected to set off a wave of mergers and acquisitions. Haitong Securities released a research report saying that the moderate price reduction of traditional Chinese medicine varieties continues. In 2024, the traditional Chinese medicine industry was under pressure due to the pressure of pharmacy terminal sales and inventory pressure, and it is expected to return to a good situation in the next 25 years. In addition, the continuous technological changes in the pharmaceutical industry, the development of IPO to mergers and acquisitions and the promotion of corporate governance optimization at the shareholder level are the main reasons for promoting mergers and acquisitions in the industry. In terms of fields, mergers and acquisitions are expected to occur intensively in sub-sectors such as medical devices, Chinese medicine, medical services, blood products and scientific research services.